Cargando…

SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements

PURPOSE: Pituitary diseases severely affect patients’ health-related quality of life (HRQoL). The most frequently used generic HRQoL questionnaire is the Short Form-36 (SF-36). The shorter 12-item version (SF-12) can improve efficiency of patient monitoring. This study aimed to determine whether SF-...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Meulen, Merel, Zamanipoor Najafabadi, Amir H., Lobatto, Daniel J., Andela, Cornelie D., Vliet Vlieland, Thea P. M., Pereira, Alberto M., van Furth, Wouter R., Biermasz, Nienke R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525280/ https://www.ncbi.nlm.nih.gov/pubmed/32562182 http://dx.doi.org/10.1007/s12020-020-02384-4

Ejemplares similares

Work disability and its determinants in patients with pituitary tumor-related disease
por: Lobatto, Daniel J., et al.
Publicado: (2018)

Healthcare utilization and costs among patients with non-functioning pituitary adenomas
por: Lobatto, Daniel J., et al.
Publicado: (2019)

Healthcare utilization and costs among prolactinoma patients: a cross-sectional study and analysis of determinants
por: van der Meulen, Merel, et al.
Publicado: (2020)

Preoperative risk factors for postoperative complications in endoscopic pituitary surgery: a systematic review
por: Lobatto, Daniel J., et al.
Publicado: (2017)

How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review
por: Andela, Cornelie D., et al.
Publicado: (2018)

Costs and Its Determinants in Pituitary Tumour Surgery
por: Dekkers, Alies J., et al.
Publicado: (2022)

Feasibility, safety, and outcomes of a stratified fast-track care trajectory in pituitary surgery
por: Lobatto, Daniel J., et al.
Publicado: (2020)

Starting point for benchmarking outcomes and reporting of pituitary adenoma surgery within the European Reference Network on Rare Endocrine Conditions (Endo-ERN): results from a meta-analysis and survey study
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2022)

State of the Art of Patient-reported Outcomes in Acromegaly or GH Deficiency: A Systematic Review and Meta-analysis
por: van der Meulen, Merel, et al.
Publicado: (2021)

Early postoperative HPA-axis testing after pituitary tumor surgery: reliability and safety of basal cortisol and CRH test
por: de Vries, Friso, et al.
Publicado: (2019)

Unmet needs and recommendations to improve meningioma care through patient, partner, and health care provider input: a mixed-method study
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis
por: de Vries, Friso, et al.
Publicado: (2019)

Validation of the SF-36 in patients with endometriosis
por: Stull, Donald E., et al.
Publicado: (2013)

Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity
por: Wee, Christina C, et al.
Publicado: (2008)

Improvement in Symptoms and Health-Related Quality of Life in Acromegaly Patients: A Systematic Review and Meta-Analysis
por: Broersen, Leonie H A, et al.
Publicado: (2020)

Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters
por: Geraedts, Victor J., et al.
Publicado: (2017)

The partner’s perspective of the impact of pituitary disease: Looking beyond the patient
por: Andela, Cornelie D, et al.
Publicado: (2017)

SUN-489 Opioid Epidemic and Related Endocrine Effects: A Systematic Review and Meta-analysis.
por: Bruin, Mees, et al.
Publicado: (2019)

Outcome Squares Integrating Efficacy and Safety, as Applied to Functioning Pituitary Adenoma Surgery
por: de Vries, Friso, et al.
Publicado: (2021)

Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension
por: Twiss, James, et al.
Publicado: (2013)

Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?
por: Pickard, A Simon, et al.
Publicado: (2005)

Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1
por: Farivar, Sepideh S, et al.
Publicado: (2007)

Health-related quality of life of cranial WHO grade I meningioma patients: are current questionnaires relevant?
por: Zamanipoor Najafabadi, Amir H., et al.
Publicado: (2017)

The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary
por: Andela, Cornelie D., et al.
Publicado: (2016)

Correction to: Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up
por: Huynh, Kevin A., et al.
Publicado: (2023)

Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up
por: Huynh, Kevin A., et al.
Publicado: (2023)

The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12
por: Hoffman, D L, et al.
Publicado: (2008)

Pituitary Adenoma Apoplexy in an Adolescent: A Case Report and Review of the Literature
por: Zijlker, Hero, et al.
Publicado: (2017)

Chiasmal herniation following treatment of pituitary macroadenoma
por: Tabak, Marjolein, et al.
Publicado: (2020)

Measurement equivalence of the SF-36 in the canadian multicentre osteoporosis study
por: Lix, Lisa M, et al.
Publicado: (2012)

Postoperative diabetes insipidus: how to define and grade this complication?
por: de Vries, Friso, et al.
Publicado: (2020)

Visual outcomes endorse surgery of patients with spheno-orbital meningioma with minimal visual impairment or hyperostosis
por: Zamanipoor Najafabadi, Amir H., et al.
Publicado: (2020)

Towards a pituitary apoplexy classification based on clinical presentation and patient journey
por: Guijt, M. C., et al.
Publicado: (2022)

Validity and Reliability of MOS Short Form Health Survey (SF-36) for Use in India
por: Sinha, Richa, et al.
Publicado: (2013)

Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review
por: Contopoulos-Ioannidis, Despina G, et al.
Publicado: (2009)

Convergent validity between SF-36 and WHOQOL-BREF in older adults
por: Castro, Paula Costa, et al.
Publicado: (2014)

Psychometric Evaluation of the SF-36(®) Health Survey in Medicare Managed Care
por: Gandek, Barbara, et al.
Publicado: (2004)

International SF-36 reference values in patients with ischemic heart disease
por: Huber, Alexandra, et al.
Publicado: (2016)

The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials
por: Strijbis, Eva MM, et al.
Publicado: (2022)

Measurement Comparisons of the Medical Outcomes Study and Veterans SF-36(®) Health Survey
por: Kazis, Lewis E., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_5etu4lueu15l021n7ckl5lk3lu